Chronic Constipation: a Review of Current Literature
- 2.2k Downloads
Chronic constipation is a common health condition representing a substantial proportion of primary care visits and referrals to specialist providers. Chronic constipation can have a significant negative effect on health-related quality of life and has been associated with psychological distress in severely affected patients. It has the potential to cause patients to curtail work, school, and social activities. While different pathophysiological mechanisms have been implicated in the development of chronic constipation, in some instances, the causes of chronic constipation are not easily determined. Expenditures for the evaluation and management of chronic constipation represent a significant burden on patients and payers, and it is important for clinicians to have a clear understanding of the different pathophysiological mechanisms associated with constipation, understand the different testing modalities and treatments that are available including their appropriateness and limitations, and tailor that knowledge to the management of individual patients.
KeywordsConstipation Chronic constipation Management of chronic constipation Pelvic floor dysfunction Dyssynergic defecation Types of constipation
Compliance with Ethics Guidelines
Conflict of Interest
Hani Sbahi declares no conflict of interest.
Brooks D. Cash reports personal fees from Takeda, Actavis, Astra Zeneca, Ironwood, and Sucampo, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 53.•Lee H, Boo S, Jung K, et al. Long-term efficacy of biofeedback therapy in patients with dyssynergic defecation: results of a median 44 months follow-up. Neurogastroenterol Motil. 2015. A trial assessing the long-term efficacy of biofeedback therapy in a large group of patients with dyssynergic defecation, concluding that biofeedback therapy is durable and efficacy was maintained for more than 2 years in a sizable proportion of constipated patients with dyssynergic defecation.Google Scholar
- 60.Cash BD, Lacy BE. Systematic review: FDA-approved prescription medications for adults with constipation. Gastroenterol Hepatol. 2006;2(10):736–49.Google Scholar
- 70.•Barish C, Drossman D, Johanson J, et al. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci. 2009;55(4):1090–7. This study assessed the efficacy and safety of lubiprostone in patients with chronic constipation. The authors concluded that lubiprostone produced a bowel movement in the majority of individuals within 24 h of initial dosing, with sustained improvement in frequency and other constipation symptoms over 4 weeks.PubMedCrossRefGoogle Scholar
- 72.•Cryer B, Katz S, Vallejo R, et al. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain. Pain Med. 2014;15(11):1825–34. In this study, the authors assessed the efficacy and safety of lubiprostone 24 mg twice daily for the treatment of OIC in adult patients with non-cancer pain. The results confirmed superior efficacy of lubiprostone compared to placebo in terms of increasing SBM frequency, improvement in abdominal discomfort, straining, constipation severity, stool consistency, and patient satisfaction. In addition, lubiprostone was well-tolerated with no serious lubiprostone-related adverse events.PubMedPubMedCentralCrossRefGoogle Scholar
- 82.Shailubhai K, Barrow L, Talluto C, et al. Plecanatide, a guanylate cyclase c agonist, improves bowel habits and symptoms associated with chronic constipation in a phase IIa clinical study. ACJ. 2011;11(S2):1174.Google Scholar
- 91.Vaughan-Shaw P, Fecher I, Harris S, et al. A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery. Dis Colon Rectum. 2012;55(5):611–20.PubMedCrossRefGoogle Scholar
- 93.•Schey R, Cromwell J, Rao S. Medical and surgical management of pelvic floor disorders affecting defecation. Am J Gastroenterol. 2012;107(11):1624–33. An excellent review of the diagnosis and management of different pelvic floor disorders causing constipation.PubMedPubMedCentralCrossRefGoogle Scholar